Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis
Key Points
Key points are not available for this paper at this time.
Abstract
EU Innovative Medicines Initiative Respiratory Syncytial Virus Consortium in Europe (RESCEU).
Like
Bookmark
Share
View Full Paper
Like
Bookmark
Share
View Full Paper
Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis | Synapse